COMPARISON OF DOSIMETRIC IN RADIOTHERAPY PLANNING FOR NON-SMALL CELL LUNG CANCER USING IMRT AND FIF TECHNIQUES AT NGHE AN ONCOLOGY HOSPITAL
Main Article Content
Abstract
Objective: This study compares the treatment planning dosimetry between the field-in-field (FiF) technique and intensity-modulated radiation therapy (IMRT) for patients with non-small cell lung cancer (NSCLC) at Nghe An Oncology Hospital, using the MONACO 5.11.03 treatment planning system. Materials and Methods: A retrospective study was conducted on 51 patients with NSCLC who underwent radiotherapy at Nghe An Oncology Hospital from January 2023 to December 2024. Dosimetric parameters including Dmax, dose–volume metrics, mean dose to the planning target volume (PTV) and organs at risk (OARs), homogeneity index (HI), conformity index (CI), monitor units (MU), and number of radiation fields were analyzed from dose–volume histograms (DVHs) using the MONACO 5.11.03 treatment planning system for each IMRT and FiF plan. All IMRT plans passed quality assurance requirements using the MiniPhantom and MatriXX Evolution system (IBA Dosimetry, Germany). Results: Among the 51 patients with NSCLC, the IMRT demonstrated superior dose coverage compared to FiF, with a mean V60Gy to the PTV of 97.9% versus 96% (p < 0.001). The homogeneity index (HI) and conformity index (CI) for IMRT were 1.05 and 0.999, respectively, compared to 1.10 and 0.995 for FiF (p < 0.001). The FiF resulted in a lower spinal cord Dmax (2992.2 ± 1239.2 cGy vs. 3517.8 ± 895.7 cGy, p < 0.001). IMRT delivered significantly lower mean doses to the heart (883.8 vs. 1447.7 cGy), contralateral lung (646.4 vs. 882 cGy), and esophagus (1869.2 vs. 2233.8 cGy), with p-values < 0.01. However, IMRT required a higher number of monitor units (776.5 vs. 250.3). Conclusion: IMRT provides better dose homogeneity and higher coverage to the PTV while reducing the dose to the OARs compared to FiF. With FiF, the maximum dose to the spinal cord is lower and the irradiation time is shorter than with IMRT. Therefore, FiF is an alternative option in cases where spinal cord protection is prioritized or when the treatment position cannot be maintained for a long period.
Article Details
Keywords
Lung cancer, NSCLC, FiF, IMRT, Dosimetric evaluation
References
2. Ren XC, Liu YE, Li J. Progress in image-guided radiotherapy for the treatment of non-small cell lung cancer. World J Radiol. Mar 28 2019;11(3):46-54. doi:10.4329/wjr.v11.i3.46
3. Nguyen Thi Lan HDV, Duong Thanh Tai and James C. L. Chow. Dosimetric comparison of intensity-modulated radiation therapy (IMRT) and field-in-field (FIF) technique for head-and-neck cancer. cambridgeorg/jrp. 2020:1 of 6. doi:10.1017/S1460396920000977
4. Ghafour H, Ali JS, Taher Ali R, Sirelkhatim E. A Comparison of Field-in-Field and Intensity Modulated Radiation Therapy in Delivering Hypofractionated Radiation Therapy for Prostate Cancer. Adv Radiat Oncol. Feb 2024;9(2):101356. doi:10.1016/j.adro.2023.101356
5. Ettinger DS, Wood DE, Aisner DL, et al. NCCN Guidelines(R) Insights: Non-Small Cell Lung Cancer, Version 2.2023. J Natl Compr Canc Netw. Apr 2023;21(4):340-350. doi:10.6004/jnccn. 2023.0020
6. Paddick I. A simple scoring ratio to index the conformity of radiosurgical treatment plans. Technical note. J. Neurosurg., vol. 93, no. SUPPL. 3, pp. 219–222. 2000;doi:10.3171/ jns.2000.93.supplement_3.0219
7. Kutob L, Schneider F. Lung Cancer Staging. Surg Pathol Clin. Mar 2020;13(1):57-71. doi:10.1016/j.path.2019.10.003
8. Phương NL, ĐAT, PTD, et al. Kết Quả Điều Trị Ung Thư Phổi Không tế Bào nhỏ Giai Đoạn III Bằng Hóa Xạ Trị Đồng Thời Với Kỹ Thuật Xạ Trị Điều Biến Liều Theo Thể Tích Hình Cung (VMAT). Tạp Chí Nghiên Cứu Y Học. 2021;145 (9) - 2021:203-211.
9. Jorgensen N, Meline EL, Jeppesen SS, Hansen O, Nielsen M, Schytte T. The effect of tumor laterality on survival for non-small cell lung cancer patients treated with radiotherapy. Acta Oncol. Oct 2019;58(10):1393-1398. doi:10.1080/ 0284186X.2019.1629011
10. Chun SG, Hu C, Komaki RU, et al. Long-Term Prospective Outcomes of Intensity Modulated Radiotherapy for Locally Advanced Lung Cancer: A Secondary Analysis of a Randomized Clinical Trial. JAMA Oncol. Aug 1 2024;10(8):1111-1115. doi:10.1001/jamaoncol.2024.1841